Skip to content

Remedy Robotics raises DCVC-led $62 million Series B toward expanding global access to life-saving cardiovascular care

The physical AI company is set to launch pivotal clinical trials and advance toward FDA approval for its endovascular robot

Every year, lack of access to stroke care leads to millions of lives lost and millions of cases of permanent disability. Though cardio­vas­cular disease remains the world’s leading cause of death, with stroke alone exacting a staggering $891 billion economic toll annually, fewer than three percent of eligible stroke patients receive the care they need. The bottleneck? A critical shortage of specialized physicians and equipment.

Remedy Robotics is changing that. By combining AI with advanced robotics to manipulate tiny catheters with precision, Remedy’s N1 System, currently in development, is designed to perform gold-standard endovas­cular procedures onsite, remotely, or even autonomously. Backing companies that bring deep tech innovation to bear on the biggest challenges the world faces is what we do here at DCVC, which is why we’re thrilled to lead the $62 million Series B Remedy announced earlier today.

Over the past year, the company has hit a number of milestones on the road to bringing this life-saving technology into real-world clinical use. In October 2025, in collab­o­ra­tion with world-renowned surgeon Dr. Vitor Mendes Pereira at St. Michael’s Hospital in Toronto, Remedy’s N1 System success­fully demon­strated the first-ever entirely remote neuroin­t­er­ven­tional procedures in human patients. The company is also moving quickly on the regulatory front and will be using this new funding to support a pivotal clinical trial in partnership with leading clinicians at the University of California. Remedy now works with more than 100 hospital partners worldwide and will soon deploy additional prototype systems through part­ner­ships with SVIN Mission Thrombec­tomy and the Australian Stroke Alliance.

Under the leadership of CEO Dr. David Bell and CTO Dr. Jake Sganga, Remedy is realizing a bold vision: ensuring your geography no longer dictates your chance of surviving a stroke. By pioneering medical robotics, the Remedy team is democ­ra­tizing life-saving care for patients everywhere.

Related Content